Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Tuberculosis

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 35 articles:
HTML format



Single Articles


    August 2022
  1. HAAS DW, Abdelwahab MT, van Beek SW, Baker P, et al
    Pharmacogenetics of Between-Individual Variability in Plasma Clearance of Bedaquiline and Clofazimine in South Africa.
    J Infect Dis. 2022;226:147-156.
    PubMed     Abstract available


    May 2022
  2. KUA KP, Chongmelaxme B, Lee S
    Association between cytomegalovirus infection and tuberculosis disease: A systematic review and meta-analysis of epidemiological studies.
    J Infect Dis. 2022 May 4. pii: 6580085. doi: 10.1093.
    PubMed     Abstract available


  3. WALKER NF, Karim F, Moosa M, Moodley S, et al
    Elevated Plasma Matrix Metalloproteinase-8 associates with Sputum Culture Positivity in Pulmonary Tuberculosis.
    J Infect Dis. 2022 May 1. pii: 6576469. doi: 10.1093.
    PubMed     Abstract available


    March 2022
  4. NGO MD, Bartlett S, Bielefeldt-Ohmann H, Foo CX, et al
    A blunted GPR183/oxysterol axis during dysglycemia results in delayed recruitment of macrophages to the lung during M. tuberculosis infection.
    J Infect Dis. 2022 Mar 18. pii: 6550675. doi: 10.1093.
    PubMed     Abstract available


    February 2022
  5. TEPEKULE B, Kusejko K, Zeeb M, Tarr PE, et al
    Impact of Latent Tuberculosis Infection on the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study.
    J Infect Dis. 2022 Feb 16. pii: 6529706. doi: 10.1093.
    PubMed     Abstract available


  6. JIA P, Zhang Y, Xu J, Zhu M, et al
    IMB-BZ as an Inhibitor Targeting ESX-1 Secretion System to Control Mycobacterial Infection.
    J Infect Dis. 2022;225:608-616.
    PubMed     Abstract available


  7. AGARWAL S, Tiwari P, Deep A, Kidwai S, et al
    Corrigendum to: System-Wide Analysis Unravels the Differential Regulation and In Vivo Essentiality of Virulence-Associated Proteins B and C Toxin-Antitoxin Systems of Mycobacterium tuberculosis.
    J Infect Dis. 2022 Feb 11. pii: 6526953. doi: 10.1093.
    PubMed    


    January 2022
  8. ZURCHER K, Riou J, Morrow C, Ballif M, et al
    Estimating Tuberculosis Transmission Risks in a Primary Care Clinic in South Africa: Modeling of Environmental and Clinical Data.
    J Infect Dis. 2022 Jan 18. pii: 6510424. doi: 10.1093.
    PubMed     Abstract available


    December 2021
  9. SAHA A, Escudero J, Layouni T, Richardson B, et al
    Mycobacterium tuberculosis-specific T cell responses are impaired during late pregnancy with elevated biomarkers of tuberculosis risk postpartum.
    J Infect Dis. 2021 Dec 20. pii: 6470923. doi: 10.1093.
    PubMed     Abstract available


  10. GERIC C, Saroufim M, Landsman D, Richard J, et al
    Impact of Covid-19 on Tuberculosis Prevention and Treatment in Canada: a multicentre analysis of 10,833 patients.
    J Infect Dis. 2021 Dec 17. pii: 6469005. doi: 10.1093.
    PubMed     Abstract available


  11. POERIO N, Caccamo N, La Manna MP, Olimpieri T, et al
    Phosphatidylserine liposomes reduce inflammatory response, mycobacterial viability and HIV replication in coinfected human macrophages.
    J Infect Dis. 2021 Dec 15. pii: 6463308. doi: 10.1093.
    PubMed     Abstract available


    November 2021
  12. HLAKA L, Ozturk M, Chia JE, Jones SS, et al
    IL-4i1 regulates immune protection during Mycobacterium tuberculosis infection.
    J Infect Dis. 2021 Nov 5. pii: 6421699. doi: 10.1093.
    PubMed     Abstract available


    October 2021
  13. ARRIAGA MB, Araujo-Pereira M, Barreto-Duarte B, Nogueira B, et al
    The Effect of Diabetes and Prediabetes on Anti-tuberculosis Treatment Outcomes: A Multi-center Prospective Cohort Study.
    J Infect Dis. 2021 Oct 15. pii: 6398049. doi: 10.1093.
    PubMed     Abstract available


    September 2021
  14. LONG R, Lau A, Egedahl ML, Paulsen C, et al
    Local Transmission Plays No Important Role in the Occurrence of Multidrug-Resistant Tuberculosis in Immigrants to Canada: An In-depth Epidemiologic Analysis.
    J Infect Dis. 2021;224:1029-1038.
    PubMed     Abstract available


  15. PIETERMAN ED, Keutzer L, van der Meijden A, van den Berg S, et al
    Superior Efficacy of a Bedaquiline, Delamanid, and Linezolid Combination Regimen in a Mouse Tuberculosis Model.
    J Infect Dis. 2021;224:1039-1047.
    PubMed     Abstract available


  16. CHEN Y, Ji L, Liu Q, Li J, et al
    Lesion Heterogeneity and Long-Term Heteroresistance in Multidrug-Resistant Tuberculosis.
    J Infect Dis. 2021;224:889-893.
    PubMed     Abstract available


    July 2021
  17. HALLIDAY A, Masonou T, Tolosa-Wright MR, Guo Y, et al
    Defining the Role of Cellular Immune Signatures in Diagnostic Evaluation of Suspected Tuberculosis.
    J Infect Dis. 2021 Jul 31. pii: 6332782. doi: 10.1093.
    PubMed     Abstract available


    May 2021
  18. ARRIAGA MB, Rocha MS, Nogueira B, Nascimento V, et al
    The Effect of Diabetes and Prediabetes on Mycobacterium tuberculosis Transmission to Close Contacts.
    J Infect Dis. 2021 May 19. pii: 6278117. doi: 10.1093.
    PubMed     Abstract available


  19. PARVEEN S, Lun S, Urbanowski ME, Cardin M, et al
    Effective host-directed therapy for tuberculosis by targeted depletion of myeloid-derived suppressor cells and related cells using a diphtheria toxin-based fusion protein.
    J Infect Dis. 2021 May 6. pii: 6270734. doi: 10.1093.
    PubMed     Abstract available


    March 2021
  20. DUFFY FJ, Olson GS, Gold ES, Jahn A, et al
    A contained Mycobacterium tuberculosis mouse infection model predicts active disease and containment in humans.
    J Infect Dis. 2021 Mar 10. pii: 6167837. doi: 10.1093.
    PubMed     Abstract available


    February 2021
  21. MUDDE SE, Alsoud RA, van der Meijden A, Upton AM, et al
    Predictive modeling to study the treatment-shortening potential of novel tuberculosis drug regimens, towards bundling of preclinical data.
    J Infect Dis. 2021 Feb 19. pii: 6145049. doi: 10.1093.
    PubMed     Abstract available


  22. RAO MUVVA J, Ahmed S, Rekha RS, Kalsum S, et al
    Immunomodulatory agents combat multidrug-resistant tuberculosis by improving antimicrobial immunity.
    J Infect Dis. 2021 Feb 19. pii: 6145048. doi: 10.1093.
    PubMed     Abstract available


  23. DUBEY N, Khan MZ, Kumar S, Sharma A, et al
    Mycobacterium tuberculosis PPiA interacts with host integrin receptor to exacerbate disease progression.
    J Infect Dis. 2021 Feb 13. pii: 6134355. doi: 10.1093.
    PubMed     Abstract available


  24. LAI CC, Tehrani B, Yungtum G, Hsu WT, et al
    Association between the use of statins and risk of tuberculosis: a real-world analysis.
    J Infect Dis. 2021 Feb 8. pii: 6131374. doi: 10.1093.
    PubMed    


  25. BEHR MA, Divangahi M, Schurr E
    Lessons From Bacille Calmette-Guerin for SARS-CoV-2 Vaccine Candidates.
    J Infect Dis. 2021;223:189-191.
    PubMed     Abstract available


    January 2021
  26. STEIN CM, Benchek P, Bartlett J, Igo RP, et al
    Methylome-wide analysis reveals epigenetic marks associated with resistance to tuberculosis in HIV-infected individuals from East Africa.
    J Infect Dis. 2021 Jan 5. pii: 6064776. doi: 10.1093.
    PubMed     Abstract available


    November 2020
  27. BARBOSA BOMFIM CC, Pinheiro Amaral E, Santiago-Carvalho I, Almeida Santos G, et al
    Granulocytic Myeloid-Derived Suppressor Cells Aggravate Tuberculosis Caused by Hypervirulent Mycobacteria.
    J Infect Dis. 2020 Nov 18. pii: 5989003. doi: 10.1093.
    PubMed     Abstract available


    October 2020
  28. DONOVAN J, Tram TTB, Phu NH, Hiep NTT, et al
    The influence of Strongyloides stercoralis co-infection on the presentation, pathogenesis and outcome of tuberculous meningitis.
    J Infect Dis. 2020 Oct 26. pii: 5940016. doi: 10.1093.
    PubMed     Abstract available


  29. HJORT K, Juren P, Toro JC, Hoffner S, et al
    Dynamics of extensive drug resistance evolution of Mycobacterium tuberculosis in a single patient during 9 years of disease and treatment.
    J Infect Dis. 2020 Oct 12. pii: 5921146. doi: 10.1093.
    PubMed     Abstract available


  30. AGARWAL S, Tiwari P, Deep A, Kidwai S, et al
    Corrigendum to: System-Wide Analysis Unravels the Differential Regulation and In Vivo Essentiality of Virulence-Associated Proteins B and C Toxin-Antitoxin Systems of Mycobacterium tuberculosis.
    J Infect Dis. 2020 Oct 7. pii: 5918919. doi: 10.1093.
    PubMed    


    June 2020
  31. DUTTA NK, Karakousis PC
    Reply to Hu et al: Could there be detrimental effects of statin adjunctive TB therapy on immune responses?
    J Infect Dis. 2020;222:336-337.
    PubMed    


    March 2020
  32. KAUSHAL D
    The Comeback Kid: BCG.
    J Infect Dis. 2020;221:1031-1032.
    PubMed    


    January 2020
  33. CLICK ES, Kurbatova E, Alexander H, Dalton TL, et al
    Isoniazid- and Rifampin-Resistance Mutations Associated with Resistance to Second-line Drugs and with Sputum Culture Conversion.
    J Infect Dis. 2020 Jan 31. pii: 5718252. doi: 10.1093.
    PubMed     Abstract available


    December 2019
  34. HU Z, Lowrie DB, Fan XY
    Statins as adjunctive therapy against tuberculosisthe balance between statin-induced anti-TB effect and trained immunity suppression.
    J Infect Dis. 2019 Dec 24. pii: 5686380. doi: 10.1093.
    PubMed    


    November 2019
  35. STOCKDALE L, Nash S, Farmer R, Raynes J, et al
    Cytomegalovirus antibody responses associated with increased risk of TB disease in Ugandan adults.
    J Infect Dis. 2019 Nov 5. pii: 5613526. doi: 10.1093.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: